MARCO
Basic information
Region (hg38): 2:118942194-118994660
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MARCO gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 5 | |||||
missense | 31 | 35 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 31 | 8 | 1 |
Variants in MARCO
This is a list of pathogenic ClinVar variants found in the MARCO region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-118942319-C-A | not specified | Uncertain significance (Feb 10, 2022) | ||
2-118942325-G-A | not specified | Uncertain significance (Jan 09, 2024) | ||
2-118942330-C-T | Likely benign (May 24, 2018) | |||
2-118942395-A-G | not specified | Likely benign (Oct 03, 2022) | ||
2-118969176-G-T | not specified | Uncertain significance (Jan 04, 2022) | ||
2-118969204-G-A | not specified | Uncertain significance (Aug 17, 2022) | ||
2-118969234-G-A | not specified | Uncertain significance (Jan 04, 2024) | ||
2-118970116-C-G | not specified | Uncertain significance (Jan 30, 2024) | ||
2-118970174-C-T | not specified | Uncertain significance (May 27, 2022) | ||
2-118970242-G-A | not specified | Uncertain significance (Dec 14, 2023) | ||
2-118970278-T-C | not specified | Uncertain significance (Oct 06, 2022) | ||
2-118970331-G-A | Likely benign (Mar 29, 2018) | |||
2-118971499-G-A | not specified | Likely benign (Sep 06, 2022) | ||
2-118971523-A-C | not specified | Uncertain significance (Apr 08, 2024) | ||
2-118971528-G-A | not specified | Uncertain significance (Jan 26, 2023) | ||
2-118974336-T-A | not specified | Uncertain significance (Apr 12, 2022) | ||
2-118974364-G-A | not specified | Uncertain significance (Dec 16, 2022) | ||
2-118974367-T-A | Likely benign (Mar 01, 2024) | |||
2-118974372-C-G | not specified | Uncertain significance (May 29, 2024) | ||
2-118974381-C-G | not specified | Uncertain significance (Nov 12, 2021) | ||
2-118974381-C-T | not specified | Likely benign (Aug 22, 2023) | ||
2-118974384-C-T | not specified | Uncertain significance (Sep 17, 2021) | ||
2-118974426-G-A | not specified | Uncertain significance (Oct 13, 2023) | ||
2-118974560-A-T | not specified | Uncertain significance (Jul 25, 2023) | ||
2-118977507-G-A | not specified | Uncertain significance (Jun 13, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MARCO | protein_coding | protein_coding | ENST00000327097 | 17 | 52495 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
7.77e-21 | 0.00187 | 125649 | 0 | 99 | 125748 | 0.000394 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.178 | 305 | 296 | 1.03 | 0.0000162 | 3289 |
Missense in Polyphen | 72 | 69.857 | 1.0307 | 782 | ||
Synonymous | -1.06 | 129 | 115 | 1.13 | 0.00000697 | 1054 |
Loss of Function | 0.0375 | 31 | 31.2 | 0.993 | 0.00000160 | 340 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000679 | 0.000665 |
Ashkenazi Jewish | 0.0000996 | 0.0000992 |
East Asian | 0.000382 | 0.000381 |
Finnish | 0.0000476 | 0.0000462 |
European (Non-Finnish) | 0.000578 | 0.000571 |
Middle Eastern | 0.000382 | 0.000381 |
South Asian | 0.000337 | 0.000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Pattern recognition receptor (PRR) which binds Gram- positive and Gram-negative bacteria (PubMed:9468508). Also plays a role in binding of unopsonized particles by alveolar macrophages (By similarity). Binds to the secretoglobin SCGB3A2 (PubMed:12847263). {ECO:0000250|UniProtKB:Q9WUB9, ECO:0000269|PubMed:12847263, ECO:0000269|PubMed:9468508}.;
- Pathway
- Phagosome - Homo sapiens (human);Vesicle-mediated transport;Binding and Uptake of Ligands by Scavenger Receptors;Scavenging by Class A Receptors
(Consensus)
Recessive Scores
- pRec
- 0.247
Intolerance Scores
- loftool
- 0.267
- rvis_EVS
- -0.37
- rvis_percentile_EVS
- 28.16
Haploinsufficiency Scores
- pHI
- 0.0640
- hipred
- N
- hipred_score
- 0.145
- ghis
- 0.389
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.624
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Marco
- Phenotype
- cellular phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); immune system phenotype;
Gene ontology
- Biological process
- positive regulation of protein phosphorylation;pattern recognition receptor signaling pathway;endocytosis;receptor-mediated endocytosis;cell surface receptor signaling pathway;adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway;apoptotic cell clearance;innate immune response;positive regulation of ERK1 and ERK2 cascade;amyloid-beta clearance
- Cellular component
- collagen trimer;plasma membrane;integral component of plasma membrane;endocytic vesicle membrane
- Molecular function
- amyloid-beta binding;G protein-coupled receptor binding;transmembrane signaling receptor activity;scavenger receptor activity;signaling pattern recognition receptor activity